Lord’s Mark Delivers First USD 1 Million MedTech Shipment to the USA
Milestone underscores India’s rising strength in advanced healthcare technology exports
Lord’s Mark Industries Limited, among India’s fastest-growing diversified business groups, has successfully completed and dispatched its first MedTech shipment to the United States. Valued at USD 1 million, the order was executed through Lord’s Mark Industries Ltd., marking a significant leap in the company’s global ambitions while spotlighting India’s growing role in cutting-edge healthcare technology.
The shipment comprises next-generation solutions, including Contactless Remote Patient Monitoring (RPM) devices and AI-enabled Early Warning Systems (EWS). Designed, developed, and produced entirely in India, these systems integrate real-time patient monitoring, predictive analytics, and Electronic Health Record (EHR) connectivity to support proactive, data-driven clinical decision-making.
Speaking on the achievement, Sachidanand Upadhyay, Managing Director, Lord’s Mark Industries Ltd., noted that this milestone strengthens India’s positioning in high-quality MedTech innovation. He emphasized that the shipment represents not merely an export transaction but India’s evolving leadership in global medical technology. Upadhyay added that the company is building world-class solutions that meet rigorous global standards, reinforcing Lord’s Mark Industries Ltd. as an influential international player while positioning Indian innovation as a reliable benchmark worldwide.
Lord’s Mark Industries Ltd. operates through subsidiaries including LordsMed, Lord’s Mark Biotech Pvt. Ltd., and Lords Mark Microbiotech Pvt. Ltd. With a strong commitment to innovation and excellence, the group continues to scale its portfolio while maintaining stringent quality compliance. Its diversified approach remains central to its sustained growth trajectory.
Established in 1998, Lord’s Mark Industries Ltd. has built a strong presence across healthcare and diagnostics. The company’s strategic expansion spans medical diagnostics, pharmaceuticals, and genome testing, significantly strengthening its footprint across the healthcare value chain.
More information is available at www.lordsmark.com.
